Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate OptiNose, Inc. before investing.

In this article, we go over a few key elements for understanding OptiNose, Inc.’s stock price such as:

• OptiNose, Inc.’s current stock price and volume
• Why OptiNose, Inc.’s stock price changed recently
• Upgrades and downgrades for OPTN from analysts
• OPTN’s stock price momentum as measured by its relative strength

About OptiNose, Inc. (OPTN)

Before we jump into OptiNose, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania.

Want to learn more about OptiNose, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about OptiNose, Inc..

OptiNose, Inc.’s Stock Price as of Market Close

As of March 20, 2025, 4:00 PM, CST, OptiNose, Inc.’s stock price was $9.150.

OptiNose, Inc. is up 52.5% from its previous closing price of $6.000.

During the last market session, OptiNose, Inc.’s stock traded between $9.090 and $9.600. Currently, there are approximately 11.62 million shares outstanding for OptiNose, Inc..

OptiNose, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

OptiNose, Inc. Stock Price History

OptiNose, Inc.’s (OPTN) price is currently up 57.49% so far this month.

During the month of March, OptiNose, Inc.’s stock price has reached a high of $9.600 and a low of $5.100.

Over the last year, OptiNose, Inc. has hit prices as high as $26.400 and as low as $4.815. Year to date, OptiNose, Inc.’s stock is up 36.98%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused OptiNose, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of March 19, 2025,, no analysts have changed their rating of OptiNose, Inc.’s stock over the last month.

Additionally, you'll want to evaluate OptiNose, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on OptiNose, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about OptiNose, Inc. (OPTN) by visiting AAII Stock Evaluator.

Relative Price Strength of OptiNose, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 19, 2025, OptiNose, Inc. has a weighted four-quarter relative price strength of -26.80%, which translates to a Momentum Score of 6 and is considered to be Very Weak.

Want to learn more about how OptiNose, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

OptiNose, Inc. Stock Price: Bottom Line

As of March 20, 2025, OptiNose, Inc.’s stock price is $9.150, which is up 52.5% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like OptiNose, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.